
Module 2: Drug Price Negotiation
Module Description
This module will examine the structure, selection process, and negotiation timeline of the Medicare Drug Price Negotiation Program under the Inflation Reduction Act (IRA). Learners will review the program's goals and anticipated impact on the healthcare system, as well as notable exceptions and special cases within the negotiation framework. Additionally, this module will discuss the implications for key healthcare groups such as payers, manufacturers, and pharmacy benefit teams, and assess how the program influences point-of-sale operations and patient access to selected medications.
Learning Objectives
At the completion of this activity, participants should be able to:
- Discuss the structure, drug selection process, and negotiation timeline under the IRA.
- Describe the impact on operations at the point-of-sale for patients and medication access for selected drugs.
- Recognize the implications for manufacturers, payers, and pharmacy benefit teams.
- Identify exceptions and special cases in the negotiation process.
- Review the goals of the Medicare Drug Price Negotiation Program and its anticipated impact on the healthcare system.
Faculty/Authors:
Geni Tunstall, JD
Associate Vice President, Regulatory Affairs
AMCP
Advisory Board and Contributing Authors
Melissa Andel, MPP
Principal
CommonHealth Solutions LLC
Crescent Moore, PharmD, PhD
SVP, Government Programs
LucyRx
Financial Relationship Disclosures:
| Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
| Geni Tunstall Author | Individual Stocks/Stock Options: CVS Caremark |
| Melissa Andel Ad board | None |
| Crescent Moore Ad board | LucyRx, Salary, Stock ownership |
| Brooke Whittington Planner | None |
- AMCP Staff have disclosed no relevant financial relationships.
- If applicable, relevant financial relationships have been mitigated and documented.
- Content has undergone a peer review to ensure content validity.
Accreditation:
ACPE UAN:0233-0000-25-065-H03-P • Activity Type: Knowledge-Based
Contact Hours: 0.25
Release Date: October 27, 2025 • Expiration Date: June 30, 2028
CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Available Credit
- 0.25 ACPEThe Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Facebook
X
LinkedIn
Forward